Elanders AB : Elanders' rights issue of approximately 125 million kronor fully subscribed

NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO
THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, SINGAPORE, SOUTH AFRICA
OR NEW ZEALAND OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OF THIS PRESS
RELEASE WOULD BE UNLAWFUL.

The results of Elanders' rights issue show that all of the Class A shares and
3,566,742 Class B shares, representing approximately 99.2 percent of the offered
shares, were subscribed for with subscription rights. In addition, requests for
subscription without subscription rights amounting to an additional 701,110
Class B shares have been received, representing approximately 18.5 percent of
the total offer. The rights issue has thereby been oversubscribed.

The 27,130 Class B shares that were not subscribed for with subscription rights
have been allocated to other subscribers in accordance with the principles
outlined in the prospectus. Notification regarding such allocation is only sent
to those who have been allocated shares. Consequently, the issue guarantee from
Carl Bennet AB has not been exercised. Through the rights issue, Elanders will
receive proceeds amounting to approximately SEK 125 million before transaction
costs.

As a result of the rights issue Elanders' share capital increases by SEK
37,883,160 to SEK 265,183,140. The total number of shares increases by
3,788,316 to 26,518,314 shares, of which 1,361,110 Class A shares and
25,157,204 Class B shares.

The new shares subscribed for with subscription rights are expected to be
registered with the Swedish Companies Registration Office on or around 10 June
2014 and the new shares subscribed for without subscription rights are expected
to be registered with the Swedish Companies Registration Office on or around 17
June 2014. The new shares are expected to start trading on NASDAQ OMX Stockholm
on or around 19 June 2014.


For further questions, please contact
Magnus Nilsson, President and CEO, telephone: +46 (0)31-750 07 50
Andréas Wikner, CFO, telephone: +46 (0)31-750 07 50


The information in this press release has been made public according to the
Swedish Securities Market Act and/or the Swedish Financial Instruments Trading
Act. This information was published at 08:00 CET on 9 June 2014.


Important information
This press release is not an offer for subscription of shares in Elanders. A
prospectus relating to the rights issue referred to in this press release has
been made public by the company prior to the commencement of the subscription
period. This press release is not a prospectus and investors should not
subscribe for or purchase any securities referred to in this press release,
except on the basis of information provided in the prospectus.

This press release may not be made public, released or distributed, directly or
indirectly, in or into the United States, Australia, Hong Kong, Japan, Canada,
Singapore, South Africa or New Zealand or any other jurisdiction in which the
distribution of this press release would be unlawful. Further, this press
release does not constitute an offer to sell new shares, paid subscribed for
shares ("BTA") or subscription rights to any person in any jurisdiction in which
it is unlawful to make such offer to such person or where such an offer would
require additional prospectuses, registration or measures other than those
pursuant to Swedish law. The prospectus, application form or other documents
associated with the rights issue may not be distributed in or to any country
where such distribution or the rights issue would require such actions set forth
in the preceding sentence or be in violation of the regulations of such
country.

The new shares, BTAs and subscription rights have not been recommended by a U.S.
federal or state securities commission or regulatory authority. No new shares,
BTAs, subscription rights or other securities issued by Elanders have been or
will be registered under the U.S. Securities Act of 1933, or under any other
securities legislation in any state of the U.S. or any province in Canada.
Accordingly, no new shares, BTAs, subscription rights or other securities issued
by Elanders may be transferred or offered for sale in the United States or
Canada, other than in such exceptional cases that do not require registration.
The securities issued in the rights issue will not be offered to the public in
the United States.

Elanders has not authorized any offer of securities to the public in any country
in the European Economic Area ("EEA") other than Sweden. In other member states
in the EEA which have implemented the Directive 2003/71/EC (the "Prospectus
Directive") (each, a "Relevant Member State"), no action has been undertaken and
will not be undertaken to make an offer of securities to the public requiring
publication of a prospectus in any Relevant Member State. As a result, the
securities may only be offered in Relevant Member States to (a) any legal entity
which is a qualified investor as defined in the Prospectus Directive; or (b) in
any other circumstances falling within Article 3(2) of the Prospectus
Directive.

The rights issue is only directed at (i) persons who are outside the United
Kingdom or (ii) persons who have professional experience in matters relating to
investments falling within Article 19(5) of the Financial Services and Markets
Act 2000 (Financial Promotion) Order 2005 (the "Order") and (iii) high net worth
entities, and other persons to whom it may lawfully be communicated, falling
within Article 49(2) of the Order (all such persons together being referred to
as "relevant persons"). The securities issued in the rights issue will only be
available to and will only be engaged with, relevant persons. Any person who is
not a relevant person should not act or rely on this document or any of its
contents.

SEB Corporate Finance is acting for Elanders and no one else in connection with
the rights issue and will not be responsible to anyone other than Elanders for
providing the protections afforded to their respective clients or for providing
advice in relation to the rights issue.


[HUG#1791017]